Segment, Customer and Geographical Reporting (Tables)

9 Months Ended

Jun. 30, 2016

The Company’s segment information for the three months ended June 30, 2016 and 2015 is summarized below:

Results of Operations for the Three Months Ended June 30, 2016
	Optics			Contract Research			Biomedical		Total
Revenue	$	5,780,000		$	4,626,000		$	-	$	10,406,000
Gross Profit		2,012,000			1,915,000			-		3,927,000
GM %		35	%		41	%		-		38	%
SG&A		1,604,000			1,601,000			396,000		3,601,000
(Gain) loss on sale of assets		-			-			-		-
Operating Income (Loss)		408,000			314,000			(396,000)		326,000

Depreciation and Amortization		247,000			24,000			17,000		288,000
Capital expenditures		330,000			-			6,000		336,000

Intangibles, Net		549,000			239,000			308,000		1,096,000
Goodwill		1,001,000			4,939,000			-		5,940,000
Total Assets	$	16,752,000		$	8,546,000		$	424,000	$	25,722,000

Results of Operations for the Three Months Ended June 30, 2015
	Optics			Contract Research			Biomedical		Total
Revenue	$	5,613,000		$	4,626,000		$	-	$	10,239,000
Gross Profit		2,006,000			2,027,000			-		4,033,000
GM %		36	%		44	%		-		39	%
SG&A		1,380,000			1,934,000			236,000		3,550,000
(Gain) loss on sale of assets		8,000			-			-		8,000
Operating Income (Loss)		618,000			93,000			(236,000)		475,000

Depreciation and Amortization		223,000			74,000			15,000		312,000
Capital expenditures		270,000			-			21,000		291,000

Intangibles, Net		722,000			273,000			257,000		1,252,000
Goodwill		1,252,000			4,939,000			-		6,191,000
Total Assets	$	16,665,000		$	9,462,000		$	756,000	$	26,883,000

The Company’s segment information for the nine months ended June 30, 2016 and 2015 is summarized below:

Results of Operations for the Nine Months Ended June 30, 2016
	Optics			Contract Research			Biomedical		Total
Revenue	$	18,415,000		$	14,484,000		$	-	$	32,899,000
Gross Profit		6,330,000			5,639,000			-		11,969,000
GM %		34	%		39	%		-		36	%
SG&A		5,237,000			5,107,000			1,099,000		11,443,000
(Gain) loss on sale of assets		(4,000)			-			-		(4,000)
Operating Income (Loss)		1,097,000			532,000			(1,099,000)		530,000

Depreciation and Amortization		700,000			187,000			52,000		939,000
Capital expenditures		1,224,000			37,000			81,000		1,342,000

Intangibles, Net		549,000			239,000			308,000		1,096,000
Goodwill		1,001,000			4,939,000			-		5,940,000
Total Assets	$	16,752,000		$	8,546,000		$	424,000	$	25,722,000

Results of Operations for the Nine Months Ended June 30, 2015
	Optics			Contract Research			Biomedical		Total
Revenue	$	15,781,000		$	13,964,000		$	-	$	29,745,000
Gross Profit		5,222,000			6,077,000			-		11,299,000
GM %		33	%		44	%		-		38	%
SG&A		4,964,000			5,712,000			739,000		11,415,000
(Gain) loss on sale of assets		(178,000)			-			-		(178,000)
Operating Income (Loss)		436,000			365,000			(739,000)		62,000

Depreciation and Amortization		631,000			222,000			45,000		898,000
Capital expenditures		666,000			4,000			77,000		747,000

Intangibles, Net		722,000			273,000			257,000		1,252,000
Goodwill		1,252,000			4,939,000			-		6,191,000
Total Assets	$	16,665,000		$	9,462,000		$	756,000	$	26,883,000

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended June 30, 2016 and 2015 are as follows:

Revenue by geographic location in total and as a percentage of total revenue, for the nine months ended June 30, 2016 and 2015 are as follows: